FindTrial
Sign In

Detection of sentinel lymph node micrometasis for cN0 laryngeal squamous cell carcinoma and identification of key microRNAs

Detection of sentinel lymph node micrometasis for cN0 laryngeal squamous cell carcinoma and identification of key microRNAs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CO-12002382
Enrollment
Unknown
Registered
2012-07-30
Start date
2012-07-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal Squamous Cell Carcinoma

Interventions

1:NA

Sponsors

No.1 Hospital Affiliated Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Palpation, B-ultrasound, CT, MRI to rule out lymph node metastasis in patients with laryngeal squamous cell carcinoma N0; 2. without radiation therapy or chemotherapy before surgery; 3. confirmed squamous cell carcinoma with histologically; 4. No effective taboos of the experimental operation; 5. cN0 laryngeal squamous cell carcinoma patients before surgery line 18F-FDG PET-CT imaging; line 99 Tc m mark sulfur colloid (99Tcm-SC) in the preoperative lymphoscintigraphy and intraoperative garma probe detection to determine patients with SLN.

Exclusion criteria

Exclusion criteria: Patiens againsted the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
18F-FDG PET-CT imaging;99Tcm-SC;key Micrornas;—

Countries

China

Contacts

Public ContactBinquan Wang
wbq_xy@yahoo.com.cn+86 0351 4639988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026